公司資料
Helius Medical Technologies 股價、新聞與催化劑
- 股票代碼:
- HSDT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
2.10 USD (+12.90%)
收盤價
最後更新: 2026年8月21日
93.4M USD
市值
股價為何變動
As of Aug 21, 2026, HSDT closed up 12.9% at $2.10. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Helius Medical Technologies is a medical technology company focused on neuromodulation and non-invasive approaches to neurological symptoms. Its business is rooted in device-based neuroscience rather than pharmaceuticals.
所在地與產業分類
Helius is headquartered in the United States and listed on NASDAQ. It sits in neurotechnology and medical devices.
商業模式特徵
The company depends on product adoption, clinical acceptance, and the ability to expand use of its neuromodulation platform. Investors usually watch commercialization progress and regulatory or reimbursement developments.
生技產業定位
Helius occupies a neuromodulation niche within healthcare technology. It is not biotech, but it sits close to the neuroscience device layer.
未來催化劑
- Helius is a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
近期新聞
- 01
- 02
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。